Stephen Wargacki Aquestive Therapeutics, Inc. (AQST) insider trading activity

AQST Quotes by TradingView

Stephen Wargacki is Chief Science Officer of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 267,963 shares of AQST, which is worth approximately $696,703. The most recent transaction as insider was on May 10, 2024, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 268K
3.88% 3M change
69.15% 12M change
Total Value Held $696,703

Stephen Wargacki Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 10 2024
BUY
Grant, award, or other acquisition
-
10,000 Added 3.6%
267,963 Common Stock
Mar 10 2024
SELL
Payment of exercise price or tax liability
$8,232 $4.88 p/Share
1,687 Reduced 0.65%
257,963 Common Stock
Mar 09 2024
SELL
Payment of exercise price or tax liability
$54,992 $4.88 p/Share
11,269 Reduced 4.16%
259,650 Common Stock
Mar 07 2024
BUY
Grant, award, or other acquisition
-
112,500 Added 29.34%
270,919 Common Stock
Mar 10 2023
SELL
Payment of exercise price or tax liability
$1,564 $0.79 p/Share
1,981 Reduced 1.24%
158,419 Common Stock
Mar 09 2023
BUY
Grant, award, or other acquisition
-
135,000 Added 45.46%
161,956 Common Stock
SW

Stephen Wargacki

Chief Science Officer
Warren, NJ

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AQST